Current multidisciplinary oncology series

por Sebio, Ana, Lenz, Heinz-Josef
Publicado 2014

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

por Sebio, Ana, Lenz, Heinz-Josef
Publicado en Clin Cancer Res (2015)

Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan‐induced severe toxicity

por Riera, Pau, Salazar, Juliana, Virgili, Anna C., Tobeña, María, Sebio, Ana, Gallano, Pía, Barnadas, Agustí, Páez, David
Publicado en Br J Clin Pharmacol (2018)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

por Riera, Pau, Artigas-Baleri, Alícia, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Arranz, María Jesús, Páez, David
Publicado en Front Pharmacol (2020)

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients ac...

por Páez, David, Tobeña, María, Fernández-Plana, Julen, Sebio, Ana, Virgili, Anna C., Cirera, Lluís, Barnadas, Agustí, Riera, Pau, Sullivan, Ivana, Salazar, Juliana
Publicado en Br J Cancer (2018)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs

por Nogales, Vanesa, Reinhold, William C., Varma, Sudhir, Martinez-Cardus, Anna, Moutinho, Catia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas, Agusti, Pommier, Yves, Esteller, Manel
Publicado en Oncotarget (2015)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

por Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado en Pharmacogenomics J (2015)

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

por Sebio, Ana, Gerger, Armin, Matsusaka, Satoshi, Yang, Dongyun, Zhang, Wu, Stremitzer, Stefan, Stintizing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Ning, Yan, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado en Pharmacogenet Genomics (2015)

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients

por Riera, Pau, Rodríguez-Santiago, Benjamín, Lasa, Adriana, Gonzalez-Quereda, Lidia, Martín, Berta, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Minguillón, Jordi, Camps, Cristina, Surrallés, Jordi, Páez, David
Publicado en Cancers (Basel) (2020)

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

por Stremitzer, Stefan, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stintzing, Sebastian, Sebio, Ana, Sunakawa, Yu, Yamauchi, Shinichi, Matsusaka, Satoshi, El-Khoueiry, Rita, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef
Publicado en Cancer (2015)

A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report

por Moura, David S., Díaz-Martín, Juan, Bagué, Silvia, Orellana-Fernandez, Ruth, Sebio, Ana, Mondaza-Hernandez, Jose L., Salguero-Aranda, Carmen, Rojo, Federico, Hindi, Nadia, Fletcher, Christopher D. M., Martin-Broto, Javier
Publicado en Int J Mol Sci (2021)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

por Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Publicado en Mol Cancer Ther (2016)

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

por Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Publicado en Pharmacogenet Genomics (2014)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

por Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado en Mol Cancer Ther (2015)

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors

por Serrano, César, Vivancos, Ana, López-Pousa, Antonio, Matito, Judit, Mancuso, Francesco M., Valverde, Claudia, Quiroga, Sergi, Landolfi, Stefania, Castro, Sandra, Dopazo, Cristina, Sebio, Ana, Virgili, Anna C., Menso, María M., Martín-Broto, Javier, Sansó, Miriam, García-Valverde, Alfonso, Rosell, Jordi, Fletcher, Jonathan A., George, Suzanne, Carles, Joan, Arribas, Joaquín
Publicado en BMC Cancer (2020)

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

por Serrano, César, García‐del‐Muro, Xavier, Valverde, Claudia, Sebio, Ana, Durán, José, Manzano, Aránzazu, Pajares, Isabel, Hindi, Nadia, Landolfi, Stefania, Jiménez, Laura, Rubió‐Casadevall, Jordi, Estival, Anna, Lavernia, Javier, Safont, María José, Pericay, Carles, Díaz‐Beveridge, Roberto, Martínez‐Marín, Virginia, Vicente‐Baz, David, Vivancos, Ana, Hernández‐Losa, Javier, Arribas, Joaquín, Carles, Joan
Publicado en Oncologist (2018)